Silverback Therapeutics, Inc. Contracts & Agreements

56 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
ARS Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Amended Effective April 1, 2025)
Compensation Agreements
Silverback Therapeutics, Inc.
Biotechnology
2025
Second Amendment to Manufacturing Agreement between ARS Pharmaceuticals Operations, Inc. and Renaissance Lakewood, LLC
Supply Agreements
Silverback Therapeutics, Inc.
Biotechnology
DE
2024
First Amendment to Manufacturing Agreement between ARS Pharmaceuticals Operations, Inc. and Renaissance Lakewood, LLC
Modification Agreements
Silverback Therapeutics, Inc.
Biotechnology
2023
Agreement and Plan of Merger and Reorganization among Silverback Therapeutics, Inc., Sabre Merger Sub, Inc., and ARS Pharmaceuticals, Inc. dated July 21, 2022
Merger Agreements
Silverback Therapeutics, Inc.
Biotechnology
DE
2022
Warrant to Purchase Series C Preferred Stock between ARS Pharmaceuticals, Inc. and Silicon Valley Bank (September 30, 2019)
Warrant Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2022
License Agreement between ARS Pharmaceuticals, Inc. and Aegis Therapeutics, LLC (June 18, 2018)
License Agreements
Silverback Therapeutics, Inc.
Biotechnology
DE
2022
License and Supply Agreement between ARS Pharmaceuticals, Inc. and Recordati Ireland, Ltd. for ARS-1
License Agreements
Silverback Therapeutics, Inc.
Biotechnology
DE
2022
Consulting Agreement between ARS Pharmaceuticals, Inc. and Brent L. Saunders
Consulting Agreements
Silverback Therapeutics, Inc.
Biotechnology
2022
Consulting Services Agreement between Silverback Therapeutics, Inc. and Laura Shawver, Ph.D.
Consulting Agreements
Silverback Therapeutics, Inc.
Biotechnology
WA
2022
Consulting Services Agreement between Silverback Therapeutics, Inc. and Jonathan Piazza
Consulting Agreements
Silverback Therapeutics, Inc.
Biotechnology
WA
2022
Second Amendment to Agreement and Plan of Merger and Reorganization among Silverback Therapeutics, Sabre Merger Sub, and ARS Pharmaceuticals
Merger Agreements
Silverback Therapeutics, Inc.
Biotechnology
2022
Second Amendment to Lease Agreement between BMR-500 Fairview Avenue LLC and Silverback Therapeutics, Inc.
Lease Agreements
Silverback Therapeutics, Inc.
Biotechnology
2022
Agreement and Plan of Merger and Reorganization among Silverback Therapeutics, Inc., Sabre Merger Sub, Inc., and ARS Pharmaceuticals, Inc.
Merger Agreements
Silverback Therapeutics, Inc.
Biotechnology
DE
2022
Lock-Up Agreement between Silverback Therapeutics, Inc. and ARS Pharmaceuticals, Inc. Stockholder (July 21, 2022)
Silverback Therapeutics, Inc.
Biotechnology
2022
Sublease Agreement between Delta Dental of Washington and Silverback Therapeutics, Inc. for Office Space at 400 Fairview Avenue North, Seattle
Lease Agreements
Silverback Therapeutics, Inc.
Biotechnology
WA
2022
Silverback Therapeutics, Inc. RSU Award Grant Notice and Agreement (2020 Equity Incentive Plan)
Equity Distribution Agreements
Silverback Therapeutics, Inc.
Biotechnology
2022
Sublease Agreement between Delta Dental of Washington and Silverback Therapeutics, Inc. for 400 Fairview Avenue N, Suite 600, Seattle, WA
Lease Agreements
Silverback Therapeutics, Inc.
Biotechnology
WA
2021
Description of Common Stock of Silverback Therapeutics, Inc.
Stock Agreements
Silverback Therapeutics, Inc.
Biotechnology
2021
Amendment No. 1 to Cell Line License Agreement between Silverback Therapeutics, Inc. and WuXi Biologics (Hong Kong) Limited
License Agreements
Silverback Therapeutics, Inc.
Biotechnology
2021
Silverback Therapeutics, Inc. Common Stock Underwriting Agreement with Goldman Sachs, SVB Leerink, and Stifel
Underwriting Agreements
Silverback Therapeutics, Inc.
Biotechnology
2020
Silverback Therapeutics, Inc. Common Stock Certificate
Stock Agreements
Silverback Therapeutics, Inc.
Biotechnology
2020
Silverback Therapeutics, Inc. 2020 Equity Incentive Plan
Equity Distribution Agreements
Silverback Therapeutics, Inc.
Biotechnology
DE
2020
Silverback Therapeutics, Inc. 2020 Employee Stock Purchase Plan
Equity Distribution Agreements
Silverback Therapeutics, Inc.
Biotechnology
2020
Amended and Restated Investors' Rights Agreement between Silverback Therapeutics, Inc. and Investors (September 22, 2020)
Investor Rights Agreements
Silverback Therapeutics, Inc.
Biotechnology
DE
2020
Warrant to Purchase Common Stock between Silverback Therapeutics, Inc. and Silicon Valley Bank (November 21, 2016)
Warrant Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2020
Warrant to Purchase Common Stock between Silverback Therapeutics, Inc. and Silicon Valley Bank
Warrant Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2020
Silverback Therapeutics, Inc. 2016 Equity Incentive Plan (as Amended through September 22, 2020)
Equity Distribution Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2020
Lease Agreement between BMR-500 Fairview Avenue LLC and Silverback Therapeutics, Inc. for 500 Fairview Avenue North, Seattle
Lease Agreements
Silverback Therapeutics, Inc.
Biotechnology
WA
2020
Cell Line License Agreement between WuXi Biologics (Hong Kong) Limited and Silverback Therapeutics, Inc.
License Agreements
Silverback Therapeutics, Inc.
Biotechnology
NY
2020
Loan and Security Agreement between Silicon Valley Bank and Silverback Therapeutics, Inc. (November 21, 2016)
Loan Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2020
ARS Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Amended June 28, 2024)
Compensation Agreements
Silverback Therapeutics, Inc.
Biotechnology
2024
ARS Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Amended December 6, 2022)
Compensation Agreements
Silverback Therapeutics, Inc.
Biotechnology
2024
Executive Employment Agreement between ARS Pharmaceuticals, Inc. and Brian T. Dorsey
Employment Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2022
Collaboration and License Agreement between ARS Pharmaceuticals, Inc. and Alfresa Pharma Corporation (April 30, 2020)
Collaboration Agreements
Silverback Therapeutics, Inc.
Biotechnology
NY
2022
Collaboration and Distribution Agreement between ARS Pharmaceuticals, Inc. and Pediatrix Therapeutics
Collaboration Agreements
Silverback Therapeutics, Inc.
Biotechnology
NY
2022
Manufacturing Agreement between Renaissance Lakewood, LLC and ARS Pharmaceuticals, Inc.
Supply Agreements
Silverback Therapeutics, Inc.
Biotechnology
NJ
2022
Executive Employment Agreement between ARS Pharmaceuticals, Inc. and Richard E. Lowenthal
Employment Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2022
Executive Employment Agreement between ARS Pharmaceuticals, Inc. and Kathleen Scott
Employment Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2022
Executive Employment Agreement between ARS Pharmaceuticals, Inc. and Dr. Sarina Tanimoto
Employment Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2022
Executive Employment Agreement between ARS Pharmaceuticals, Inc. and Eric Karas
Employment Agreements
Silverback Therapeutics, Inc.
Biotechnology
PA
2022
Executive Employment Agreement between ARS Pharmaceuticals, Inc. and Justin Chakma
Employment Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2022
Consulting Agreement between ARS Pharmaceuticals, Inc. and Marlinspike Group, LLC (Effective September 13, 2018)
Consulting Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2022
Master Services Agreement between ARS Pharmaceuticals, Inc. and Pacific-Link Regulatory Consulting, Inc.
Services Agreements
Silverback Therapeutics, Inc.
Biotechnology
2022
Consulting Services Agreement between Silverback Therapeutics, Inc. and Valerie Odegard
Consulting Agreements
Silverback Therapeutics, Inc.
Biotechnology
WA
2022
Support Agreement between ARS Therapeutics, Inc. and Stockholder Regarding Silverback Therapeutics, Inc. Merger
Voting Agreements
Silverback Therapeutics, Inc.
Biotechnology
DE
2022
Support Agreement between Silverback Therapeutics, Inc. and Stockholder of ARS Pharmaceuticals, Inc. (July 21, 2022)
Voting Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2022
Silverback Therapeutics, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
Silverback Therapeutics, Inc.
Biotechnology
2022
Silverback Therapeutics, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
Silverback Therapeutics, Inc.
Biotechnology
2020
Indemnity Agreement between Silverback Therapeutics, Inc. and Indemnitee
Indemnification Agreements
Silverback Therapeutics, Inc.
Biotechnology
DE
2020
Silverback Therapeutics, Inc. Employment Agreement with Laura Shawver as President and CEO (March 2020)
Employment Agreements
Silverback Therapeutics, Inc.
Biotechnology
2020
Silverback Therapeutics, Inc. Employment Offer Letter to Valerie Odegard (Sr. Vice President, Translational Sciences)
Employment Agreements
Silverback Therapeutics, Inc.
Biotechnology
2020
Silverback Therapeutics, Inc. Employment Agreement with Naomi Hunder, MD (Sr. Vice President, Clinical Research and Development)
Employment Agreements
Silverback Therapeutics, Inc.
Biotechnology
2020
Silverback Therapeutics, Inc. Employment Offer Letter to Jonathan Piazza (Chief Financial Officer)
Employment Agreements
Silverback Therapeutics, Inc.
Biotechnology
2020
Master Laboratory Services Agreement between Silverback Therapeutics, Inc. and Q Squared Solutions LLC
Services Agreements
Silverback Therapeutics, Inc.
Biotechnology
NY
2020
Master Services Agreement between CE3, Inc. and Silverback Therapeutics, Inc. (January 21, 2020)
Services Agreements
Silverback Therapeutics, Inc.
Biotechnology
WA
2020
Silverback Therapeutics, Inc. Change in Control and Severance Benefit Plan
Change of Control Agreements
Silverback Therapeutics, Inc.
Biotechnology
WA
2020